on
11th European Biosimilars Congress
April 26-27, 2018 Rome, Italy
Home ABOUT OPEN ACCESS CONFERENCES JOURNALS FAQs BLOG CONTACT
Euro Biosimilars 2018
Home
Gallery
Euro Biosimilars 2018 Report

Conference Series hosted the 11th European Biosimilars Congress at Holiday Inn Rome Aurelia via Aurelia, Km 8.400 00165 Rome, Italy during April 26-27, 2018. The conference was designed around the theme of The developmental strategies and uptake of biosimilars through a decade in Europe and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering. Moreover, the networking sessions laid the foundation for some time worthy collaborations between many start-up and big industries. The post conference networking lunch session witnessed a number of B2B meetings that are turning up to be mutually beneficial to both the organizations who had gone in for the business meetings.

Euro Biosimilars 2018 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Biologics and Biosimilars. This congress not only brought forward the latest developments in the field but also provided solutions to the numerous challenges encountered in developing a biosimilars.

Conference Series would like to convey a warm gratitude to all the Honorable guests, Keynote Speakers, Delegates, Media Partners and Exhibitors for their participation in Euro Biosimilars 2018.

Andras Guttman, SCIEX, USA

Fiona M Greer, SGS Life Sciences, Switzerland

David Ebsworth, Vifor Pharma Ltd, Switzerland

Parastoo Azadi, Complex Carbohydrtae Research Center - University of Georgia, USA

Cecil Nick, PAREXEL International, UK

Dominic Seitz, Simon-Kucher & Partners, Germany

Sakae Tsuda, National Institute of Advanced Industrial Science and Technology, Japan

Kamali Chance, BioSciencesCorp, USA

Roberta Bursi, InsilicoTRIALS, Italy

Oleksandr Kukharchuk, ReeLabs Pvt. Ltd., India

We on behalf of the conference specially thank the exhibitors for their participation in the congress and also the media partners for their wonderful marketing of the event. Conference Series also took the privilege of felicitating Euro Biosimilars 2018 Organizing Committee, Keynote Speakers and Chair whose support made conference a great success.

With the enormous feedback from the participants and supporters of Euro Biosimilars 2018, we are glad to announce 12th European Biosimilars Congress during April 15-16, 2019 at Berlin, Germany.



Expert Presentations
Kurt R Karst

Hyman, Phelps & McNamara

USA
Fiona M Greer

SGS Life Sciences

Switzerland
David Ebsworth

Vifor Pharma Ltd

Switzerland
Sakae Tsuda

National Institute of Advanced Industrial Science and Technology

Japan
Emile Van Corven

Bioceros

Netherlands
Thomas Kofoed

Alphalyse A/S

Denmark
R Helena Bustos-Cruz

Universidad de La Sabana

Colombia
M. Carme Parés Santilari

European Bio Immune(G)ene Medicine Association

France
Andras Guttman

SCIEX

USA
Kamali Chance

BioSciencesCorp

USA
Archana Shubhakar

Ludger Ltd

UK
Theo Christie

National Institute for Health Research

UK
Roberto Valenti

DLA Piper

Italy
Fatemeh Torkashvand

Pasteur Institute of Iran

Iran
Yazan Shaban

Hikma Pharmaceuticals

Jordan
Parastoo Azadi

Complex Carbohydrtae Research Center - University of Georgia

USA
Cecil Nick

PAREXEL International

UK
Dominic Seitz

Simon-Kucher & Partners

Germany
Roberta Bursi

InsilicoTRIALS

Italy
Victor Tsetlin

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS

Russia
Thomas Zahel

Exputec GmbH

Austria
Eraldo Martins Guerra Filho

Recife Center for Advanced Studies and Systems

Brazil
Oleksandr Kukharchuk

ReeLabs Pvt. Ltd

India
Menachem Zucker

E3D Elcam Drug Delivery Devices

Israel
Padma Priya Anand Baskaran

ReeLabs Pvt. Ltd

India
Mourad F Rezk

Medical and Scientific Affairs

Switzerland
















Conference Secretariat: Euro Biosimilars 2018, Conference Series Conferences
47 Churchfield Road, London, W3 6AY, UK,
Tel: +44-800-014-8923 , Fax: +44-203-004-1517
Toll free: 1-800-216-6499(USA & Canada),
1-800-651-097(Australia), 0805-080048(Europe)
Operated by: Editors - Journal of Bioanalysis & Biomedicine, Journal of Bioequivalence & Bioavailability and Journal of Pharmaceutical Sciences & Emerging Drugs
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2008-2012 Conference Series - All rights reserved